Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [APC protein affects the susceptibility to 1 and 2-Dimethylhydrazine] which results in increased expression of CPSF2 mRNA | CTD | PMID:27840820 | 1,2-dimethylhydrazine | decreases expression | ISO | Cpsf2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of CPSF2 mRNA | CTD | PMID:22206623 | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Cpsf2 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30294300 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | CPSF2 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:31675489 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Cpsf2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CPSF2 mRNA | CTD | PMID:19770486 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CPSF2 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cpsf2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CPSF2 mRNA | CTD | PMID:21570461 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of CPSF2 mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of CPSF2 mRNA | CTD | PMID:21346803 | 3,4-methylenedioxymethamphetamine | decreases expression | EXP | | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of CPSF2 mRNA | CTD | PMID:30071829 | 3-chloropropane-1,2-diol | increases expression | EXP | | 6480464 | alpha-Chlorohydrin results in increased expression of CPSF2 protein | CTD | PMID:34915118 | 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1 and 2-dithiol-3-thione results in decreased expression of CPSF2 mRNA | CTD | PMID:19162173 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of CPSF2 mRNA | CTD | PMID:30047161 | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of CPSF2 mRNA | CTD | PMID:30047161 | aristolochic acid A | decreases expression | ISO | CPSF2 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of CPSF2 mRNA | CTD | PMID:33212167 | arsenite(3-) | multiple interactions | ISO | CPSF2 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to CPSF2 mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | increases expression | ISO | Cpsf2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of CPSF2 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | increases methylation | ISO | Cpsf2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of CPSF2 exon and Benzo(a)pyrene results in increased methylation of CPSF2 intron | CTD | PMID:27901495 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CPSF2 mRNA | CTD | PMID:25181051 | bisphenol A | decreases methylation | ISO | CPSF2 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of CPSF2 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | ISO | CPSF2 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of CPSF2 protein | CTD | PMID:31675489 | butanal | decreases expression | ISO | CPSF2 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of CPSF2 mRNA | CTD | PMID:26079696 | caffeine | increases phosphorylation | ISO | CPSF2 (Homo sapiens) | 6480464 | Caffeine results in increased phosphorylation of CPSF2 protein | CTD | PMID:35688186 | chlorpyrifos | decreases expression | ISO | Cpsf2 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of CPSF2 mRNA | CTD | PMID:37019170 | ciguatoxin CTX1B | affects expression | ISO | Cpsf2 (Mus musculus) | 6480464 | Ciguatoxins affects the expression of CPSF2 mRNA | CTD | PMID:18353800 | clofibrate | decreases expression | ISO | Cpsf2 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of CPSF2 mRNA | CTD | PMID:17585979 | copper(II) sulfate | decreases expression | ISO | CPSF2 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of CPSF2 mRNA | CTD | PMID:19549813 | crocidolite asbestos | decreases expression | ISO | Cpsf2 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of CPSF2 mRNA | CTD | PMID:29279043 | cylindrospermopsin | increases expression | ISO | CPSF2 (Homo sapiens) | 6480464 | cylindrospermopsin results in increased expression of CPSF2 mRNA | CTD | PMID:24921660 | decabromodiphenyl ether | decreases expression | ISO | CPSF2 (Homo sapiens) | 6480464 | decabromobiphenyl ether results in decreased expression of CPSF2 protein | CTD | PMID:31675489 | deoxynivalenol | increases expression | ISO | CPSF2 (Homo sapiens) | 6480464 | deoxynivalenol results in increased expression of CPSF2 mRNA | CTD | PMID:31863870 | dorsomorphin | multiple interactions | ISO | CPSF2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPSF2 mRNA | CTD | PMID:27188386 | doxorubicin | increases expression | ISO | CPSF2 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of CPSF2 mRNA | CTD | PMID:29803840 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of CPSF2 mRNA | CTD | PMID:24136188 | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of CPSF2 mRNA | CTD | PMID:24793618 | formaldehyde | decreases expression | ISO | CPSF2 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of CPSF2 mRNA | CTD | PMID:23649840 | FR900359 | decreases phosphorylation | ISO | CPSF2 (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of CPSF2 protein | CTD | PMID:37730182 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of CPSF2 mRNA | CTD | PMID:22061828 | glyphosate | increases expression | EXP | | 6480464 | Glyphosate results in increased expression of CPSF2 mRNA | CTD | PMID:26302742 | hydrogen peroxide | affects expression | ISO | CPSF2 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of CPSF2 mRNA | CTD | PMID:20044591 | ivermectin | decreases expression | ISO | CPSF2 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of CPSF2 protein | CTD | PMID:32959892 | lead(0) | affects expression | ISO | CPSF2 (Homo sapiens) | 6480464 | Lead affects the expression of CPSF2 mRNA | CTD | PMID:28903495 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of CPSF2 gene | CTD | PMID:35440735 | Monobutylphthalate | decreases expression | EXP | | 6480464 | monobutyl phthalate results in decreased expression of CPSF2 mRNA | CTD | PMID:29162477 | nickel atom | decreases expression | ISO | Cpsf2 (Mus musculus) | 6480464 | Nickel results in decreased expression of CPSF2 mRNA | CTD | PMID:18922574 | nickel atom | increases expression | ISO | CPSF2 (Homo sapiens) | 6480464 | Nickel results in increased expression of CPSF2 mRNA | CTD | PMID:24768652 and PMID:25583101 | nickel atom | decreases expression | ISO | CPSF2 (Homo sapiens) | 6480464 | Nickel results in decreased expression of CPSF2 mRNA | CTD | PMID:23195993 | paracetamol | affects expression | ISO | Cpsf2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of CPSF2 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | ISO | CPSF2 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of CPSF2 mRNA | CTD | PMID:21420995 | pentachlorophenol | increases expression | ISO | Cpsf2 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of CPSF2 mRNA | CTD | PMID:23892564 | pentanal | decreases expression | ISO | CPSF2 (Homo sapiens) | 6480464 | pentanal results in decreased expression of CPSF2 mRNA | CTD | PMID:26079696 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Cpsf2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CPSF2 mRNA | CTD | PMID:36331819 | phenobarbital | affects expression | ISO | Cpsf2 (Mus musculus) | 6480464 | Phenobarbital affects the expression of CPSF2 mRNA | CTD | PMID:23091169 | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of CPSF2 mRNA | CTD | PMID:30047161 | propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of CPSF2 mRNA | CTD | PMID:30047161 | SB 431542 | multiple interactions | ISO | CPSF2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPSF2 mRNA | CTD | PMID:27188386 | silver atom | decreases expression | ISO | Cpsf2 (Mus musculus) | 6480464 | Silver results in decreased expression of CPSF2 mRNA | CTD | PMID:27131904 | silver(0) | decreases expression | ISO | Cpsf2 (Mus musculus) | 6480464 | Silver results in decreased expression of CPSF2 mRNA | CTD | PMID:27131904 | sodium arsenite | decreases expression | ISO | Cpsf2 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of CPSF2 protein | CTD | PMID:29044176 | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of CPSF2 mRNA | CTD | PMID:30047161 | tetrachloromethane | decreases expression | ISO | Cpsf2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of CPSF2 mRNA | CTD | PMID:17484886 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of CPSF2 mRNA | CTD | PMID:34492290 | titanium dioxide | increases expression | ISO | Cpsf2 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of CPSF2 mRNA | CTD | PMID:23409001 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of CPSF2 mRNA | CTD | PMID:33387578 | trichostatin A | decreases expression | ISO | CPSF2 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of CPSF2 mRNA | CTD | PMID:26272509 | trichostatin A | affects expression | ISO | CPSF2 (Homo sapiens) | 6480464 | trichostatin A affects the expression of CPSF2 mRNA | CTD | PMID:28542535 | trichostatin A | multiple interactions | ISO | CPSF2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPSF2 mRNA | CTD | PMID:27188386 | Triptolide | decreases expression | EXP | | 6480464 | triptolide results in decreased expression of CPSF2 protein | CTD | PMID:32519852 | urethane | decreases expression | ISO | CPSF2 (Homo sapiens) | 6480464 | Urethane results in decreased expression of CPSF2 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | CPSF2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CPSF2 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | CPSF2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CPSF2 mRNA | CTD | PMID:23179753 more ... | valproic acid | decreases methylation | ISO | CPSF2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of CPSF2 gene | CTD | PMID:29154799 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of CPSF2 mRNA | CTD | PMID:23034163 | |